SCIENTIFIC INDUSTRIES INC
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. EXECUTIVE COMPENSATION
The following table summarizes all compensation paid by the Company to its Chief Executive Officer, Chief Financial Officer and the two other most highly compensated executive officers for the years ended December 31, 2024 and 2023.
SUMMARY COMPENSATION TABLE
| Name and Principal · Stock · Option · Plan · Compensation · All Other | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Position | Year | Salary($) | Bonus($) | Award ($) | Awards($) | Compensation ($) | Earnings($) | Compensation ($ (5) | Total($) |
| (a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) |
| Helena R. Santos, CEO, President (1) | 12/31/2024 | 192,430 | 0 | 0 | 204,828 | 0 | 0 | 7,697 | 404,955 |
| Helena R. Santos, CEO, President | 12/31/2023 | 218,900 | 0 | 0 | 0 | 0 | 0 | 8,800 | 227,700 |
| John A. Moore, Chairman (2) | 12/31/2024 | 149,306 | 0 | 0 | 209,491 | 0 | 0 | 5,972 | 364,769 |
| John A. Moore, Chairman | 12/31/2023 | 188,000 | 0 | 0 | 0 | 0 | 0 | 7,500 | 195,500 |
| Reginald Averilla, CFO (3) | 12/31/2024 | 195,000 | 19,500 | 0 | 69,514 | 0 | 0 | 7,800 | 291,814 |
| Reginald Averilla, CFO | 12/31/2023 | 182,500 | 17,000 | 0 | 0 | 0 | 0 | 7,300 | 206,800 |
| Daniel Donadille,CEO of Bioprocessing Operations (4) | 12/31/2024 | 168,000 | 0 | 0 | 168,572 | 0 | 0 | 0 | 336,572 |
| Daniel Donadille,CEO of Bioprocessing Operations | 12/31/2023 | 193,700 | 0 | 0 | 0 | 0 | 0 | 0 | 193,700 |
| (1) | The amount of Option Awards for 2024 represents compensation expense for stock options granted valued utilizing the Black-Scholes-Merton options pricing model disregarding estimates of forfeitures related to service-based vesting considerations. |
| (2) | The amount of Option Awards for 2024 represents compensation expense for stock options granted valued utilizing the Black-Scholes-Merton options pricing model disregarding estimates of forfeitures related to service-based vesting considerations. |
| (3) | The amount of Option Awards for 2024 represents compensation expense for stock options granted valued utilizing the Black-Scholes-Merton options pricing model disregarding estimates of forfeitures related to service-based vesting considerations. |
| (4) | The amount of Option Awards for 2024 represents compensation expense for stock options granted valued utilizing the Black-Scholes-Merton options pricing model disregarding estimates of forfeitures related to service-based vesting considerations. |
| (5) | The amounts represent the Company’s matching contribution under the Company’s 401(k). |
Employment Agreements
Helena Santos
The Company has an employment agreement with Helena Santos, its President and CEO, which expires on June 30, 2025. The agreement provided for an annual base salary of $175,000 for the year ended June 30, 2018, with subsequent annual increases of 3% or the applicable annual percentage increase in the U.S. Consumer Price Index (“CPI”), whichever is higher, plus a discretionary bonus. The agreement contains a provision that within one year of a change of control, if either the Company terminates the employment for any reason other than for “cause” or the President terminates the employment for “good reason”, the President will have the right to receive a lump sum payment equal to three times the average of their total annual compensation paid for the last five years preceding such termination. The employment agreement also contains a termination provisions stipulating that if the Company terminates the employment other than for death, disability, or cause (as such term is defined therein), or if the relevant employee resigns for “good reason” (as such term is defined therein), the Company shall pay severance payments equal to one year’s salary at the rate of the compensation at the time of termination, and continue to pay the regular benefits provided by the Company for a period of one year from termination.
Reginald Averilla
The Company has an employment agreement with its Chief Financial Officer, which expires on June 30, 2025, providing for an annual base salary of $195,000 plus 10% discretionary bonus*.*The agreement contains a provision that within one year of a change of control, if either the Company terminates the employment for any reason other than for “cause” or the employee terminates the employment for “good reason”, the employee will have the right to receive a lump sum payment equal to one times the average of their total annual compensation paid for the last five years preceding such termination. The employment agreement also contains a termination provisions stipulating that if the Company terminates the employment other than for death, disability, or cause (as such term is defined therein), or if the relevant employee resigns for “good reason” (as such term is defined therein), the Company shall pay severance payments equal to one year’s salary at the rate of the compensation at the time of termination, and continue to pay the regular benefits provided by the Company for a period of one year from termination.
John A. Moore
The Company has an employment agreement with its chairman, which expires on June 30, 2024, and was extended through June 30, 2025. The agreement provides for an annual base salary of $175,000 for the year ended June 30, 2021, with subsequent annual increases of 3% plus discretionary bonuses. The agreement also provides for a grant of options to purchase 215,366 shares which were authorized by the Board of Directors during the year ended June 30, 2020, subject to amendment of the Company’s 2012 Stock Option Plan to increase the number of shares authorized for issuance thereunder which was approved in February 2021, following which Mr. Moore’s options were issued on February 23, 2021. The employment agreement contains termination provisions stipulating that if the Company terminates the employment other than for death, disability, or cause (as such term is defined therein), or if the employee resigns for “good reason”(as such term is defined in the agreement) , the Company shall pay severance payments equal to either one year’s salary at the rate of the compensation at the time of termination is employee is terminated within 12 months of the date of the agreement or six months’ salary is the employee is terminated after 12 months of the date of the agreement. The Company will continue to pay the regular benefits provided by the Company for the period equal to the length of the severance payments and pay a pro rata portion of any bonus achieved prior to such termination of employment.
Daniel Donadille
The Company has employment agreements with the Chief Executive Officer of Aquila for an indefinite term, which can be terminated by either party upon a twelve-month written notice, in accordance with German law. The agreement provides for an annual base salary of 213,000 euros, which was reduced by 25% starting April 1, 2024 under the Company’s salary reduction program. The agreement includes a retention bonus of 25,000 euros if the employees do not terminate their employment with the Company within two years after the agreement date or the Company does not terminate their employment for good cause.
| OUTSTANDING EQUITY (OPTIONS) AWARDSFor the Year Ended December 31, 2024 | |||||
|---|---|---|---|---|---|
| Name | Number Of SecuritiesUnderlying UnexercisedOptions (#)Exercisable | Number Of Securities Underlying Unexercised Options(#)Unexercisable | Equity Incentive Plan Awards Number of Securities Underlying Unexercised Unearned Options(#) | Option Exercise Price ($) | Option Expiration Date |
| (a) | (b) | (c) | (d) | (e) | (f) |
| Helena Santos | 101,593 | 185,873 | - | 2.50-3.08 | 07/2027-04/2034 |
| John A. Moore | 60,446 | 167,506 | - | 2.50-11.30 | 03/2029-04/2034 |
| Reginald Averilla | 4,444 | 15,556 | - | 2.50 | 04/2034 |
| Daniel Donadille | 61,790 | 77,162 | - | 2.50 | 04/2034 |
| Robert Nichols | 8,240 | 10,787 | - | 2.50 | 04/2034 |
| Karl Nowosielski | 2,222 | 7,778 | - | 2.50 | 04/2034 |
| DIRECTORS’ COMPENSATIONFor the Year Ended December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Name · Fees Earned or Paid in Cash($) · Stock Awards ($) · Option Awards ($) · Non-Equity Incentive Plan Compensation ($) · Non-qualified Deferred Compensation Earnings ($) · All Other Compensation ($) · Total($) | ||||||||
| (a) · (b) · (c) · (d) · (e) · (f) · (h) · (i) | ||||||||
| Michael Blechman (1) | 11,500 | 0 | 22,158 | 0 | 0 | 33,658 | ||
| Christopher Cox (2) | 16,500 | 0 | 24,298 | 0 | 0 | 40,798 | ||
| John Nicols (3) | 12,000 | 0 | 58,295 | 0 | 0 | 96,000 | 166,295 | |
| Jurgen Schumacher (4) | 12,000 | 0 | 18,916 | 0 | 0 | 30,916 | ||
| Marcus Frampton (5) | 6,000 | 0 | 13,588 | 0 | 0 | 19,588 | ||
| (1) | On May 17, 2024, 25,000 stock options were granted to Mr. Blechman, and on the same date 7,186 options were awarded to Mr. Blechman in lieu of $6,000 cash fees owed. On July 1, 2024, 5,000 stock options were granted to Mr. Blechman. Stock option expense was determined utilizing the Black-Scholes-Merton option pricing model. |
| (2) | On April 1, 2024, 17,964 stock options were awarded to Mr. Cox in lieu of $15,000 cash fees owed. On July 1, 2024, 15,000 stock options were granted to Mr. Cox. Stock option expense was determined utilizing the Black-Scholes-Merton option pricing model. |
| (3) | On April 1, 2024, 10,778 stock options were awarded to Mr. Nicols in lieu of $9,000 cash fees owed. On July 1, 2024, 15,000 stock options were granted to Mr. Nicols. Stock option expense was determined utilizing the Black-Scholes-Merton option pricing model. Please refer to Item 13 below for discussion of “All Other Compensation” amounts. |
| (4) | On April 1, 2024, 14,371 stock options were awarded to Dr. Schumacher in lieu of $12,000 cash fees owed. On July 1, 2024, 10,000 stock options were granted to Dr. Schumacher. Stock option expense was determined utilizing the Black-Scholes-Merton option pricing model. |
| (5) | On April 1, 2024, 8,962 stock options were awarded to Mr. Frampton in lieu of $7,500 cash fees owed. Mr. Frampton resigned from the Company’s Board of Directors on April 4, 2024. Stock option expense was determined utilizing the Black-Scholes-Merton option pricing model. |
The Company paid each Director who is not an employee of the Company or a subsidiary, a quarterly retainer fee of $3,000 and a meeting fee of $3,000 for each meeting attended. In addition, the Company reimburses each Director for out-of-pocket expenses incurred in connection with attendance at board meetings.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.